The licensed intellectual property covers methods and designs for CAR constructs engineered to function in myeloid cell populations
The new patents cover critical advancements in cochlear implant technology
The portfolio includes foundational patents on the production, composition, and commercial use of NR
Marks remarkable acceleration in innovation using AI technology
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
On his visit to NIPER Mohali, union health minister vreviews biopharma research initiatives and calls for stronger industry collaboration and commercialization focus
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
The deals, tied to cases in the US District Court for the District of Delaware, effectively extend US patent protection for VYNDAMAX until June 1, 2031
Subscribe To Our Newsletter & Stay Updated
